BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28228222)

  • 1. [Surgical Treatment and Prognosis for Patients with 
Synchronous Multiple Primary Lung Adenocarcinomas].
    Peng Y; Wang H; Xie H; Ren W; Feng Z; Li M; Peng Z
    Zhongguo Fei Ai Za Zhi; 2017 Feb; 20(2):107-113. PubMed ID: 28228222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical treatment is an effective approach for patients with synchronous multiple primary lung cancers.
    Peng Y; Ren W; Wang H; Li M; Feng Z; Peng Z
    J Cancer Res Ther; 2017; 13(4):702-706. PubMed ID: 28901318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical outcomes of one-stage resection for synchronous multiple primary lung adenocarcinomas with no less than three lesions.
    Qu R; Tu D; Ping W; Cai Y; Zhang N; Fu X
    J Cardiothorac Surg; 2021 Sep; 16(1):265. PubMed ID: 34544453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic lung cancer subtype differentiates synchronous multiple primary lung adenocarcinomas from intrapulmonary metastases.
    Cheng H; Lei BF; Peng PJ; Lin YJ; Wang XJ
    J Surg Res; 2017 May; 211():215-222. PubMed ID: 28501120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathology and genetic profile of synchronous multiple small adenocarcinomas: implication for surgical treatment of an uncommon lung malignancy.
    Lin MW; Wu CT; Kuo SW; Chang YL; Yang PC
    Ann Surg Oncol; 2014 Aug; 21(8):2555-62. PubMed ID: 24643899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical results of synchronous multiple primary lung cancers: similar to the stage-matched solitary primary lung cancers?
    Yu YC; Hsu PK; Yeh YC; Huang CS; Hsieh CC; Chou TY; Hsu HS; Wu YC; Huang BS; Hsu WH
    Ann Thorac Surg; 2013 Dec; 96(6):1966-74. PubMed ID: 24021769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUVmax and Tumor Size Predict Surgical Outcome of Synchronous Multiple Primary Lung Cancers.
    Hsu HH; Ko KH; Chou YC; Lin LF; Tsai WC; Lee SC; Chang H; Huang TW
    Medicine (Baltimore); 2016 Feb; 95(6):e2351. PubMed ID: 26871768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Survival after surgical treatment of bilateral synchronous multiple primary non-small cell lung cancers].
    Zhang ZR; Mao YS; Gao SG; Mu JW; Xue Q; Wang DL; Gao YS; Zhao J; He J
    Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):460-5. PubMed ID: 27346405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatments for multiple primary adenocarcinoma of the lung.
    Nakata M; Sawada S; Yamashita M; Saeki H; Kurita A; Takashima S; Tanemoto K
    Ann Thorac Surg; 2004 Oct; 78(4):1194-9. PubMed ID: 15464469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Features and Surgical Treatment of Synchronous Multiple Primary Lung Adenocarcinomas With Different EGFR Mutations.
    Qu R; Ye F; Tu D; Cai Y; Fu X
    Front Oncol; 2021; 11():785777. PubMed ID: 35096585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical treatment of primary lung cancer with synchronous brain metastases.
    Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Testing in Multiple Synchronous Lung Adenocarcinomas: Case Report and Literature Review.
    Rafael OC; Lazzaro R; Hasanovic A
    Int J Surg Pathol; 2016 Feb; 24(1):43-6. PubMed ID: 26350052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
    Kadota K; Sima CS; Arcila ME; Hedvat C; Kris MG; Jones DR; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2016 Dec; 40(12):1579-1590. PubMed ID: 27740967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonality status of multifocal lung adenocarcinomas based on the mutation patterns of EGFR and K-ras.
    Takamochi K; Oh S; Matsuoka J; Suzuki K
    Lung Cancer; 2012 Mar; 75(3):313-20. PubMed ID: 22209037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on 21 cases of multiple primary lung cancer].
    Li L; Yang L; Liu Y; Zhao C; Lin D; Wu N; Liu X; Gao Y
    Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(11):844-7. PubMed ID: 24854753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomas.
    Guerrera F; Renaud S; Tabbó F; Voegeli' AC; Filosso PL; Legrain M; Boita M; Schaeffer M; Beau-Faller M; Ruffini E; Falcoz PE; Inghirami G; Oliaro A; Massard G
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):680-688. PubMed ID: 28329143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How should synchronous multiple primary adenocarcinomas of the lung be resected?
    Yasuda M; Nagashima A; Haro A; Saitoh G
    Ann Thorac Surg; 2014 May; 97(5):e151-3. PubMed ID: 24792307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of synchronous primary lung adenocarcinomas based on epidermal growth factor (EGFR) gene status: A case report.
    Takuwa T; Tanaka F; Yoneda K; Torii I; Hashimoto M; Okumura Y; Matsumoto S; Kondo N; Hasegawa S
    Lung Cancer; 2010 Jun; 68(3):498-500. PubMed ID: 20307913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of epidermal growth factor receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: comparison with clinical guidelines.
    Girard N; Deshpande C; Azzoli CG; Rusch VW; Travis WD; Ladanyi M; Pao W
    Chest; 2010 Jan; 137(1):46-52. PubMed ID: 19376842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surgical treatment and prognosis of synchronous double primary lung cancer: a report of 31 cases].
    Feng FY; Zhang DC; Liu XY; Wang YG; Mao YS
    Ai Zheng; 2005 Feb; 24(2):215-8. PubMed ID: 15694037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.